Cofactor Genomics Overview

  • Founded

  • 2008

Founded
  • Status

  • Private

  • Employees

  • 14

Employees
  • Latest Deal Type

  • Series B

  • Latest Deal Amount

  • $6.91M

  • Investors

  • 26

Cofactor Genomics General Information

Description

Developer of a biotechnology platform designed to help in RNA sequencing and expression analysis. The company's platform examines RNA biomarkers known to be associated with response to targeted therapeutics, enabling biotech companies to commercialize a suite of clinical diagnostic assays targeting oncologic, immunologic, and neurodegenerative diseases

Contact Information

Website
www.cofactorgenomics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Database Software
Drug Discovery
Primary Office
  • 4044 Clayton Avenue
  • Saint Louis, MO 63110
  • United States
+1 (314) 000-0000

Cofactor Genomics Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cofactor Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 16-Dec-2021 $6.91M 000.00 000.00 Completed Generating Revenue
5. Later Stage VC (Series AA) 22-Dec-2020 00.00 000.00 000.00 Completed Generating Revenue
4. Accelerator/Incubator 000.00 Completed Generating Revenue
3. Later Stage VC (Series A) 14-Jun-2017 0000 000.00 000.00 Completed Generating Revenue
2. Accelerator/Incubator 18-Aug-2015 $120K $120K 00.000 Completed Generating Revenue
1. Grant 21-Jul-2015 $1.66M Completed Generating Revenue
To view Cofactor Genomics’s complete valuation and funding history, request access »

Cofactor Genomics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series AA 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A-4 000,000 00.000000 00.0 00.00 00.00 00 00.00 0.000
Series A-3 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A-2 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A-1 137,988 $0.000010 $0.06 $0.72 $0.72 1x $0.72 0.28%
Series A 14,660,342 $0.000010 $0.18 $2.2 $2.2 1x $0.85 77.78%
To view Cofactor Genomics’s complete cap table history, request access »

Cofactor Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biotechnology platform designed to help in RNA sequencing and expression analysis. The company's platform
Biotechnology
Saint Louis, MO
14 As of 2023
000.00
00.00 0000-00-00
00000000000 000.00

0000 0

xercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute i
0000000000000
Houston, TX
00 As of 0000
000000&0

000000

magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco labori
0000 000000000
Menlo Park, CA
000 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cofactor Genomics Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gene By Gene Formerly Accelerator/Incubator backed Houston, TX 00 000000&0
0000000000 Formerly VC-backed Menlo Park, CA 000 00000 00000000 00000
000000 00000000 Corporation Salt Lake City, UT 0000 00000 000000 - 000 00000
0000000 Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
000000000 Formerly VC-backed Pune, India 00 00000000000
You’re viewing 5 of 10 competitors. Get the full list »

Cofactor Genomics Patents

  • 15

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Cofactor Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4055180-A1 Methods and systems of processing complex data sets using artificial intelligence and deconvolution Pending 05-Nov-2019 000000000
US-20210133592-A1 Methods and systems of processing complex data sets using artificial intelligence and deconvolution Pending 05-Nov-2019 000000000
US-20190018926-A1 Immuno-oncology applications using next generation sequencing Active 14-Jul-2017 0
US-10636512-B2 Immuno-oncology applications using next generation sequencing Active 14-Jul-2017 000000000
US-20200227138-A1 Immuno-oncology applications using next generation sequencing Pending 14-Jul-2017 G16B30/00
To view Cofactor Genomics’s complete patent history, request access »

Cofactor Genomics Executive Team (3)

Name Title Board Seat Contact Info
Jarret Glasscock Ph.D Co-Founder, Chief Executive Officer & Board Member
David Messina Ph.D Co-Founder, Board Member & Chief Operating Officer
You’re viewing 2 of 3 executive team members. Get the full list »

Cofactor Genomics Board Members (14)

Name Representing Role Since
Cheryl Morley Self Board Member & Advisor 000 0000
David Messina Ph.D Cofactor Genomics Co-Founder, Board Member & Chief Operating Officer 000 0000
David Smoller Ph.D BioGenerator Board Member & Advisor 000 0000
David Spencer Self Board Member 000 0000
Eric Duncavage MD Self Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Cofactor Genomics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cofactor Genomics Investors (26)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Avenue Asset Management Asset Manager Minority 000 0000 000000 0
Mission and Market Angel Group Minority 000 0000 000000 0
Fifty Years Venture Capital Minority 000 0000 000000 0
Lagomaj Capital Venture Capital Minority 000 0000 000000 0
7percent Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 26 investors. Get the full list »

Cofactor Genomics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 02-Feb-2016 0000000000 Biotechnology 000000 00
To view Cofactor Genomics’s complete acquisitions history, request access »

Ready to get started?

Request a free trial